Sun Pharma Advanced Research Company Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on February 09, 2026
SPARC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sun Pharma Advanced Research Company Limited (SPARC) has submitted the proceedings of its Extraordinary General Meeting held on February 9, 2026 to the stock exchange, as required under listing regulations. This is a routine compliance filing confirming that the EGM took place. The specific resolutions approved or discussed at the meeting are not detailed in the headline. Shareholders would need to refer to the attached voting results and resolution details for the full outcome of the meeting.
This is a procedural disclosure with no immediate material impact on the stock price. Investors should review the attached EGM voting results to understand any business decisions, fund-raising plans, or governance changes that may have been approved at the meeting.